Indorse Token to US Dollar (IND/USD)

Spread: 2359.1 IND/USD Time: 06:39:11

0.0023596

Bid/Ask: 0.0011795 / 0.0035386 High/Low: 0.0143836 / 0.0014945 Chg/Chg%: +0.0007279 / +44.61%
Technical Analysis Historical Data News & Analysis

IND/USD NEWS

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program By RENAISSTHERA - 1 month ago

BENGALURU, India, June 10, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (RenaissThera), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery pro… [+2716 chars]...

Read more
Idorsia’s QUVIVIQ expands into China as Simcere receives NDA approval – Idorsia and Simcere update their licensing agreement By Idorsia - 2 weeks ago

Ad hoc announcement pursuant to Art. 53 LR

  • Idorsia to receive USD 50 million (an additional USD 30 million) approval milestone payment in return for a reduction in Simcere potential sales mi… [+5223 chars]...

    Read more
Grand Chess Tour: Carlsen Has The Last Laugh! By Site Author - 5 days ago

Carlsen ended the event with 22.5 points, 2.5 points ahead of American Wesley So who finished second while India's D Gukesh eventually came third with 19.5. IMAGE: Manus Carlsen has now won 10 out o… [+2366 chars]...

Read more
Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030 By FN - 3 weeks ago

PALM BEACH, Fla., June 18, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The market for abuse-deterrent opioids is still developing, but it's estimated that replacing extended-release opi… [+15495 chars]...

Read more
PharmaTher Secures Key US Patent for Ketamine in Amyotrophic Lateral Sclerosis (ALS), Bolstering its Orphan Drug Designated Program and Targeting a Billion Dollar Market By Site Author - 2 weeks ago

TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("PharmaTher" or the "Company"), a company focused on unlocking the pharmaceutical potential of ketamine… [+6876 chars]...

Read more
NeOnc Technologies Signs $50 Million Non-Binding Strategic Term Sheet with Quazar Investment to Launch GCC & MENA Expansion and Clinical Trials Platform By Site Author - 3 days ago

CALABASAS, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biotechnology company advancing transformative treatments for brain and central… [+7961 chars]...

Read more
Top Crypto
PairPrice Chg
BTC/USD 117840.0 +260
+0.22%
LTC/USD 93.354 -1.428
-1.51%
ETC/USD 18.43003 -0.08
-0.43%
XRP/EUR 2.37682 +0.18281
+8.33%
BTC/EUR 100298.2 -97.6
-0.1%
BTC/AUD 178452.00 +70.725
+0.04%
BTC/JPY 17337100 +47352
+0.27%
ETH/JPY 432650 +31200
+7.77%